Astellas Pharma awards DTC, HCP business to CMI, Compas and WPP Media
Astellas confirmed CMI won the business, while the agency declined to comment. Perhaps Astellas’ most notable product is Veozah (fezolinetant), a treatment for vasomotor symptoms (VMS) related to menopause, which has been the subject of major advertising …